Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab

Author:

Zhang Yanyan,Pei Zhaohui,Chen Beijian,Qu Yanling,Dong Xiaolin,Yu Binge,Wang Guoqin,Xu Fang,Lu Dongmei,He Zhimei,Chen Benchao,Ma Lei,Wang Max,Li Baiyong,Xia Michelle,Zheng Bo,Huo Yong

Funder

Henan Provincial Key Laboratory of Medical Polymer Materials Technology and Application, Tuoren Medical Device Co., Ltd.

Publisher

Elsevier BV

Reference33 articles.

1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur. Heart J.,2017

2. Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series;Ference;J. Am. Coll. Cardiol.,2018

3. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Arch Intern Med 1988, 148(1):36-69.

4. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Stone;Circulation,2014

5. Beneficial cardiovascular pleiotropic effects of statins;Davignon;Circulation,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3